spacer
home > ebr > autumn 2017 > avoiding data overload
PUBLICATIONS
European Biopharmaceutical Review

Avoiding Data Overload

Automation is one way of coping with large numbers of repetitive cell screening assays and handling of biological specimens required by the pharmaceutical industry – in the search for new therapeutics, for example. Advances in robotics and computerised equipment, such as microscopes and other technologies, mean that automation is now a more affordable possibility. Full-scale systems incorporate coordinated hardware for practical sample handling protocols linked to software packages for data handling and analysis.

The ability to standardise multiple procedures in automated protocols is particularly advantageous, allowing compliance with enforced statutory regulations of laboratory and manufacturing practice. Such automated workflows have the ability to deliver a high volume of reproducible, high-quality data while saving time and increasing efficiency and accuracy. However, while automation offers many benefits, scientists can often underestimate the significant data load generated by robotic workflows. This can quickly become unmanageable, slowing processes, producing backlogs and ultimately preventing the system from reaching the full capacity for which it was designed.

Careful Planning

The installation of automated systems in a lab is driven by a need to increase output, improve efficiency and, thereby, provide a good return on investment. A build-only solution concentrating on hardware design may appear to be cost-effective, but planning for data handling and analysis during the installation period can save time and expense in the future. The mechanical and computational intricacy of automation systems can be let down by overly complicated operating systems. However, platforms controlled by easy-to-use touch screen interfaces – which require minimal operator training and provide logical step-by-step instructions – are available.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Rob Harkness is a Business Development Manager at Peak Analysis and Automation. Here, he is responsible for business and technical development, which involves designing and delivering lab software solutions to the life sciences sector. Rob has over 15 years’ experience in the life sciences automation market and is responsible for leading groups through the full product lifecycle of lab automation products, ensuring efficient integration through analysing requirements and recommending appropriate solutions.
spacer
Rob Harkness
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Oxford Genetics licenses SnapFast™ expression vectors to Twist Bioscience

November 16, 2017, Oxford, England and San Francisco, US. – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, announced today a new licensing agreement with Twist Bioscience Corporation, a company enabling customers to succeed through its offering of rapid, high-quality synthetic DNA. Oxford Genetics will supply Twist Bioscience with its SnapFast™ technology platform to provide a broad range of application-specific expression vectors which Twist Bioscience will use to clone synthesized DNA for its diverse customer base.
More info >>

White Papers

Soothing the Logistical Headache of Clinical Trials

Equilibrium Travel Management

As many as 30 per cent of subjects on phase three clinical studies drop out.  Gruelling schedules, high travel costs and time waiting for expense reimbursement can all be factors in these fall rates, and this can be very problematic, delaying or even leading to the cancellation of the trial.  It is crucial to keep subjects motivated, and through efficient travel and expense management, this can be achieved.
More info >>

 
Industry Events

ASPIRE: International EDGE Conference

28 February - 1 March 2018, The Vox Conference Centre, Birmingham

The ASPIRE international conference is taking place on the 28th February and 1st March 2018 at the Vox Conference Centre in Birmingham. The conference brings together members of the research community including research professionals from the NHS, Clinical Trial Networks and international organisations. The ASPIRE conference will allow delegates to share knowledge and best practise with the focus on enhancing the efficiency and productivity of clinical research across the UK and beyond.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement